End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
156.5 TWD | +0.32% | +0.97% | +0.32% |
02-27 | Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-09 | Grape King Bio Hits Record-High Sales of NT$10.64 Billion in 2023 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.32% | 711M | - | ||
+8.20% | 7.78B | D+ | ||
+0.34% | 7.38B | C- | ||
+10.20% | 6.52B | - | ||
-8.10% | 3.67B | D | ||
-14.57% | 1.17B | - | - | |
+8.34% | 934M | - | ||
-42.27% | 879M | B+ | ||
-18.90% | 836M | C+ | ||
-16.45% | 802M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1707 Stock
- Ratings Grape King Bio Ltd